Cyclic peptides are of particular interest due to their pharmacological properties, but their design for binding to a target protein is challenging. Here, the authors present a computational “anchor extension” methodology for de novo design of cyclic peptides that bind to the target protein with high affinity, and validate the approach by developing cyclic peptides that inhibit histone deacetylases 2 and 6
This paper presents the design and study of a first-in-class cyclic peptide inhibitor against the SA...
Over the last decade several families of naturally occurring cyclic peptides have been discovered th...
Drug design against proteins to cure various diseases has been studied for several years. Numerous d...
Cyclic peptides are a promising class of bioactive molecules potentially capable of modulating 'diff...
An emerging class of therapeutic molecules are cyclic peptides with over 40 cyclic peptide drugs cur...
In medicinal chemistry and chemical biology, researchers are constantly expanding the chemical space...
Isoform selective histone deacetylase (HDAC) inhibitors are urgently required to investigate HDAC is...
A growing body of research has demonstrated that targeting intrinsically disordered proteins (IDPs) ...
Cyclic peptides have recently emerged as promising modulators of challenging protein‐protein interac...
Peptides are a rapidly growing class of therapeutics with various advantages over traditional small ...
Intracellular regulatory pathways are replete with protein-protein and protein-DNA interactions, off...
Thesis (Ph.D.)--University of Washington, 2021Cyclic peptides fill an intermediate niche between tra...
Chemical probes for chromatin reader proteins are valuable tools for investigating epigenetic regula...
Herein, we compared the ability of linear and cyclic peptides generated in silico to target differen...
Herein, we compared the ability of linear and cyclic peptides generated in silico to target differen...
This paper presents the design and study of a first-in-class cyclic peptide inhibitor against the SA...
Over the last decade several families of naturally occurring cyclic peptides have been discovered th...
Drug design against proteins to cure various diseases has been studied for several years. Numerous d...
Cyclic peptides are a promising class of bioactive molecules potentially capable of modulating 'diff...
An emerging class of therapeutic molecules are cyclic peptides with over 40 cyclic peptide drugs cur...
In medicinal chemistry and chemical biology, researchers are constantly expanding the chemical space...
Isoform selective histone deacetylase (HDAC) inhibitors are urgently required to investigate HDAC is...
A growing body of research has demonstrated that targeting intrinsically disordered proteins (IDPs) ...
Cyclic peptides have recently emerged as promising modulators of challenging protein‐protein interac...
Peptides are a rapidly growing class of therapeutics with various advantages over traditional small ...
Intracellular regulatory pathways are replete with protein-protein and protein-DNA interactions, off...
Thesis (Ph.D.)--University of Washington, 2021Cyclic peptides fill an intermediate niche between tra...
Chemical probes for chromatin reader proteins are valuable tools for investigating epigenetic regula...
Herein, we compared the ability of linear and cyclic peptides generated in silico to target differen...
Herein, we compared the ability of linear and cyclic peptides generated in silico to target differen...
This paper presents the design and study of a first-in-class cyclic peptide inhibitor against the SA...
Over the last decade several families of naturally occurring cyclic peptides have been discovered th...
Drug design against proteins to cure various diseases has been studied for several years. Numerous d...